Key regions: Australia, United States, India, Europe, China
The Digestive & Intestinal Remedies (Pharmacies) market in Australia & Oceania is experiencing steady growth due to customer preferences for natural and organic products, increasing awareness of digestive health, and the presence of local special circumstances. Customer preferences in the Digestive & Intestinal Remedies (Pharmacies) market in Australia & Oceania are shifting towards natural and organic products. Consumers are becoming more health-conscious and are seeking remedies that are free from artificial ingredients and chemicals. This preference for natural products is driving the demand for digestive remedies made from herbal and plant-based ingredients, as well as probiotics and prebiotics. Customers are also looking for products that are sustainably sourced and environmentally friendly, further driving the demand for natural and organic options. One of the key trends in the Digestive & Intestinal Remedies (Pharmacies) market in Australia & Oceania is the increasing awareness of digestive health. People are becoming more educated about the importance of maintaining a healthy digestive system and are actively seeking remedies to address common digestive issues such as indigestion, bloating, and constipation. This trend is driving the demand for a wide range of digestive remedies, including antacids, laxatives, and digestive enzyme supplements. The market is also witnessing a growing interest in products that promote gut health and support a balanced microbiome. Local special circumstances in Australia & Oceania are contributing to the development of the Digestive & Intestinal Remedies (Pharmacies) market. The region is known for its vast natural resources and biodiversity, which provides a rich source of ingredients for natural and herbal remedies. Local manufacturers are leveraging these resources to develop innovative products that cater to the growing demand for natural digestive remedies. Additionally, the region has a strong tradition of indigenous medicine, which has influenced the development of traditional herbal remedies for digestive health. Underlying macroeconomic factors also play a role in the development of the Digestive & Intestinal Remedies (Pharmacies) market in Australia & Oceania. The region has a stable economy and a growing middle class, which has led to increased disposable income and higher spending on healthcare products. This, coupled with the rising awareness of digestive health, is driving the demand for digestive remedies. Furthermore, the region has a well-established healthcare system and a high level of access to pharmacies, making it convenient for consumers to purchase these products. In conclusion, the Digestive & Intestinal Remedies (Pharmacies) market in Australia & Oceania is developing due to customer preferences for natural and organic products, increasing awareness of digestive health, the presence of local special circumstances, and underlying macroeconomic factors. The market is witnessing a shift towards natural and organic remedies, driven by the growing health-consciousness of consumers. The increasing awareness of digestive health is also driving the demand for a wide range of digestive remedies. Local special circumstances, such as the region's natural resources and indigenous medicine, are contributing to the development of innovative products. Finally, the stable economy and high level of access to pharmacies in the region are supporting the growth of the market.
Data coverage:
The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.Modeling approach:
Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.Additional notes:
The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
